Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Surprising CPAP Findings Should Not Discourage Development – NEJM

This article was originally published in The Gray Sheet

Executive Summary

Manufacturers should continue to develop continuous positive airway pressure technology to improve cardiovascular outcomes, despite a new trial showing that the procedure does not improve mortality in heart failure patients with central sleep apnea, according to an editorial in the Nov. 10 New England Journal of Medicine.

You may also be interested in...

Atrial Overdrive Pacing Could Benefit Some Sleep Apnea Sufferers – NEJM

Atrial overdrive pacing will continue to play only a small role in the treatment of sleep apnea, Daniel Gottlieb, MD, Boston University predicts in a New England Journal of Medicine editorial

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts